| Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example TM Alshammari, AF Altebainawi, KA Alenzi Saudi Pharmaceutical Journal 28 (7), 898-902, 2020 | 133 | 2020 |
| Energy drinks and population health: consumption pattern and adverse effects among Saudi population GM Subaiea, AF Altebainawi, TM Alshammari BMC Public Health 19, 1-12, 2019 | 56 | 2019 |
| Public knowledge, attitude and practice toward diabetes mellitus in Hail region, Saudi Arabia M Aljofan, A Altebainawi, MN Alrashidi International Journal of General Medicine, 255-262, 2019 | 31 | 2019 |
| Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study K Al Sulaiman, GB Korayem, AF Altebainawi, S Al Harbi, A Alissa, ... Critical Care 26 (1), 304, 2022 | 24 | 2022 |
| Knowledge and attitude of analgesics use among Saudi population: A cross-sectional study N Karami, AF Altebainawi, SA Alfarki, N Aldossari, A Asiri, M Aldahan, ... Int J Med Sci Public Health 7 (2), 137-142, 2018 | 24 | 2018 |
| Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide TM Alshammari, KA Alenzi, FA Alnofal, G Fradees, AF Altebainawi Saudi Pharmaceutical Journal 29 (5), 391-409, 2021 | 14 | 2021 |
| Current situation of medication errors in Saudi Arabia: a nationwide observational study TM Alshammari, KA Alenzi, Y Alatawi, AS Almordi, AF Altebainawi Journal of Patient Safety 18 (2), e448-e453, 2022 | 13 | 2022 |
| The role of inhaled corticosteroids (ICS) in critically Ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, K Al Aamer, O Al Shaya, A Al Shaya, ... Journal of Intensive Care Medicine 37 (2), 248-257, 2022 | 12 | 2022 |
| Completeness of medication prescriptions: Prescription errors study in Hail region, Saudi Arabia (PeSHR) AF Altebainawi, M Aljofan, MN Alrashidi, TM Alshammari International journal of advanced and applied sciences 6 (12), 1-6, 2019 | 11 | 2019 |
| The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study K Al Sulaiman, O Aljuhani, HA Badreldin, GB Korayem, AA Alenazi, ... BMC infectious diseases 23 (1), 75, 2023 | 8 | 2023 |
| Association of medication storage with diabetes control: A cross-sectional study from Saudi Arabia AF Altebainawi, MN Alrashidi, MK Aljbreen, MM Aziz, AA Alhifany, ... Saudi Pharmaceutical Journal 28 (4), 452-459, 2020 | 7 | 2020 |
| Association between proton pump inhibitors and rhabdomyolysis risk: A post-marketing surveillance using FDA adverse event reporting system (FAERS) database AF Altebainawi, LA Alfaraj, AA Alharbi, FF Alkhuraisi, TM Alshammari Therapeutic Advances in Drug Safety 14, 20420986231154075, 2023 | 6 | 2023 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
| The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study GB Korayem, O Aljuhani, AF Altebainawi, AI Al Shaya, LI Alnajjar, A Alissa, ... International Journal of Infectious Diseases 122, 252-259, 2022 | 6 | 2022 |
| Evaluation of low-dose aspirin use among critically Ill patients with COVID-19: A multicenter propensity score matched study AF Al Harthi, O Aljuhani, GB Korayem, AF Altebainawi, RS Alenezi, ... Journal of Intensive Care Medicine 37 (9), 1238-1249, 2022 | 6 | 2022 |
| The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, GB Korayem, AF Altebainawi, S Al Harbi, ... Frontiers in Public Health 10, 877944, 2022 | 6 | 2022 |
| Statins and risk of thrombosis in critically ill patients with COVID-19: a multicenter cohort study S Al Harbi, R Kensara, O Aljuhani, GB Korayem, AF Altebainawi, ... Clinical and Applied Thrombosis/Hemostasis 28, 10760296221103864, 2022 | 6 | 2022 |
| Biostatistical analysis knowledge of pharmacy research in the Kingdom of Saudi Arabia YA Alomi, AF Altebainawi, AA Alharbi, AA Alabdullatif ISPOR Europe. Copenhagen, Denmark 22 (S3), S779, 2019 | 6 | 2019 |
| Health economic burden of COVID-19 in Saudi Arabia KA Alenzi, HS Al-Malky, AF Altebainawi, HQ Abushomi, FO Alatawi, ... Frontiers in Public Health 10, 927494, 2022 | 5 | 2022 |
| Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study K Al Sulaiman, GB Korayem, K Eljaaly, AF Altebainawi, O Al Harbi, ... Scientific Reports 12 (1), 9766, 2022 | 5 | 2022 |
Thamir AlshammariMedication Safety Research Chair, King Saud University, Saudi Food andVerifierad e-postadress på sfda.gov.sa
